iGEM reposted this
iGEM Zurich 2022 publishes their project on sensing and mitigating Inflammatory Bowel Disease (IBD) using a novel probiotic kit in ACS Synthetic Biology. Their modular system comprises three components: a transcription factor-based sensor (NorR) capable of detecting the inflammation biomarker nitric oxide (NO), a type 1 hemolysin secretion system, and a therapeutic cargo consisting of a library of humanized anti-TNFα nanobodies. You can read more about their research on our website: https://lnkd.in/dHhFPx55
MSc Biotechnology Student @ ETHZ | Application Developer @ University Hospital Basel | Co-Founder of Hephaistos | Talent Kick Spring 2024 Batch
4wWow! Congratulations 🥳